Dopaminergic effects of lergotrile: Possible involvement of a metabolite
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 19 (6) , 537-542
- https://doi.org/10.1016/0028-3908(80)90023-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dopaminergic effects of non-hydroxylated rigid analogs of apomorphineEuropean Journal of Pharmacology, 1979
- Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptineLife Sciences, 1979
- Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitaryLife Sciences, 1977
- BROMOCRIPTINE AND DOPAMINE RECEPTOR STIMULATIONBritish Journal of Clinical Pharmacology, 1976
- Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 1976
- Inhibition of phenylalanine hydroxylase activity by α-methyl tyrosine, a potent inhibitor of tyrosine hydroxylaseLife Sciences, 1975
- Studies on the antiparkinsonian efficacy of lergotrileNeurology, 1975
- Behavioral and biochemical interaction between AMT and (+)-Amphetamine: Relevance to the identification of the functional pool of brain catecholaminesPsychopharmacology, 1975
- Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNSPsychopharmacology, 1965